dalteparin has been researched along with Bright Disease in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pless, T | 1 |
| Loertzer, H | 1 |
| Brandt, S | 1 |
| Radke, J | 1 |
| Fornara, P | 1 |
| Soukup, J | 1 |
1 other study available for dalteparin and Bright Disease
| Article | Year |
|---|---|
[Atraumatic retroperitoneal hemorrhage--interdisciplinary and differential diagnostic considerations based on a case report].
Topics: Aged; Anticoagulants; Biopsy, Needle; Diagnosis, Differential; Enoxaparin; Female; Glomerulonephriti | 2003 |